Ex-footballer Diego Forlan made his tennis debut as he and doubles partner Federico Coria of Argentina fell to a 6-1, 6-2 ...

The young Spaniard, in the on-court interview after beating Andrey Rublev, 'took stock' of his physical condition ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Sportradar Third Quarter 2024 Earnings Conference Call. At this time, all ...

in an all-stock deal valued at $3.25 billion. The company is also considering the sale of the Miami Open and Madrid Open ...

Endeavor said it will sell two of its properties to OB Global Holdings LLC, in a management buyout backed by Endeavor CEO Ari ...

Foreign companies are expanding capacity in Vietnam for testing and packaging chips while domestic firms are eyeing investments, as a shifting of industrial activity away from China gathers pace due ...

Sportradar Group AG (SRAD) reports a 27% revenue increase and raises full-year guidance amid strategic investments and market challenges.

Sam Slutsky, an analyst from LifeSci Capital, maintained the Buy rating on OnKure Therapeutics (OKUR – Research Report). The associated ...

About Levosimendan (TNX-101, TNX-102, TNX-103) Levosimendan is a unique, potassium ATP channel activator and calcium sensitizer ... Tenax Therapeutics’ common stock is listed on The Nasdaq Stock ...

An international team of scientists has made a major breakthrough in understanding how and when the Sun formed about 4.6 ...

Dr. Ehlers joins MPM BioImpact from Apple Tree Partners (ATP), where he served as Chief Scientific Officer and General Partner. At ATP, Dr. Ehlers founded and held executive leadership or Board roles ...